Drug developed at UC Davis may prevent breast cancer, treat post-menopausal vaginal atrophy
2nd Nov 2005, 16:09 GMT
A tamoxifen-like drug developed by UC Davis and Finnish researchers, now in clinical testing as a treatment for vaginal atrophy, may also help to prevent breast cancer, two preliminary studies suggest.
Drug developed at UC Davis may prevent breast cancer, treat post-menopausal vaginal atrophy related news:
- Researchers unveil reliable new approach to cancer drug delivery — Physics Org
- Researchers Develop Compound To Decrease Breast Cancer Risk — ABC 7 News
- Research unveils new, reliable approach to drug delivery for cancer patients — EurekAlert! - Cancer
- Evening primrose oil could help beat breast cancer — the Mail online | Home
- Can Exercise Stop Cancer? — EuroScience.Net
- AACR: A Diet High In Cabbage May Help Prevent Breast Cancer — MedPage Today Pediatrics
- UC Davis report: Aggies seek top-16 football ranking — SacBee -- colleges
- Herbal hope in breast cancer battle — Scotsman.com News - Cancer research
- Cancer Drug Could Fight Scleroderma (HealthDay) —
- Hot flushes distressing for breast cancer patients (Reuters) — Yahoo! News: Health News
Latest news from EurekAlert! - Medicine and Health:
- Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years
- Enbrel first biologic with up to 9 years rheumatoid arthritis safety, sustained efficacy data
- UCSD computer scientist wins Young Investigator Award, research on snake venom proteins highlighted
- Why do insects like to eat some plants more than others?
- Opposites do not attract
- Wild gorillas carriers of an SIV virus close to the AIDS virus
- New data show ACTOS (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT
- Pourquié lab identifies genes involved in formation of vertebral precursors
- Artificial cornea offers better results for infants, some blind patients
- Healthier kids just the click of a remote away